Direct generation of functional dopaminergic neurons from mouse and human fibroblasts

Nature

Volumn 476, Issue 7359, 2011, Pages 224-227

  Caiazzo, Massimiliano ^a   Dell'Anno, Maria Teresa ^a   Dvoretskova, Elena ^b   Lazarevic, Dejan ^c,d   Taverna, Stefano ^b   Leo, Damiana ^b   Sotnikova, Tatyana D ^b   Menegon, Andrea ^a   Roncaglia, Paola ^d   Colciago, Giorgia ^a   Russo, Giovanni ^b   Carninci, Piero ^e   Pezzoli, Gianni ^f   Gainetdinov, Raul R ^b   Gustincich, Stefano ^d,g   Dityatev, Alexander ^b   Broccoli, Vania ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c CBM Srl Area Science Park   (Italy)

^d SISSA   (Italy)

^e RIKEN YOKOHAMA INSTITUTE   (Japan)

^f PARKINSON INSTITUTE   (Italy)

^g Giovanni Armenise Harvard   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NUCLEAR RECEPTOR RELATED FACTOR 1; TRANSCRIPTION FACTOR LMX1A; TRANSCRIPTION FACTOR MASH1; UNCLASSIFIED DRUG;

CARCINOGENESIS; DONOR; DOPAMINERGIC NERVE CELL; ELECTRIC ACTIVITY; FIBROBLAST; HUMAN; LETTER; NERVE CELL DIFFERENTIATION; NONHUMAN; PACEMAKER; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRENATAL PERIOD; PRIORITY JOURNAL; SPIKE;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELLS, CULTURED; DOPAMINE; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; MICE; NEURONS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NUCLEAR REPROGRAMMING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; PATCH-CLAMP TECHNIQUES; REGENERATIVE MEDICINE; SKIN;

EID: 80051674431     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10284     Document Type: Letter

References (36)

1. Lindvall, O. & Björklund, A. Cell therapy in Parkinson's disease. NeuroRx 1, 382-393 (2004). (Pubitemid 46589366)
2. Politis, M. et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2, 38-46 (2010).
3. Kim, J. H. et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418, 50-56 (2002).
4. Barberi, T. et al. Neural subtype specification of fertilization and nuclear transfer embryonicstem cells and application in park insonianmice. Nature Biotechnol. 21, 1200-1207 (2003). (Pubitemid 37186177)
5. Wernig, M. et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 5856-5861 (2008). (Pubitemid 351758462)
6. Heins, N. et al. Glial cells generate neurons: the role ofthe transcription factor Pax6. Nature Neurosci. 5, 308-315 (2002). (Pubitemid 34279810)
7. Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041 (2010).
8. Ang, S.-L. Transcriptional controlofmidbrain dopaminergic neuron development. Development 133, 3499-3506 (2006). (Pubitemid 44614274)
9. Smidt, M. P. & Burbach, J. P. How to make a mesodiencephalic dopaminergic neuron. Nature Rev. Neurosci. 8, 21-32 (2007). (Pubitemid 46011996)
10. Sawamoto, K. et al. Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc. Natl Acad. Sci. USA 98, 6423-6428 (2001). (Pubitemid 32488253)
11. Perlmann, T. & Wallén-Mackenzie, A. Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res. 318, 45-52 (2004). (Pubitemid 39366053)
12. Stadtfeld, M., Maherali, N., Breault, D. T. & Hochedlinger, K. Defining molecular cornerstones during fibroblasttoiPS cell reprogramminginmouse. Cell Stem Cell 2, 230-240 (2008).
13. Grace, A. A. & Bunney, B. S. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4, 2866-2876 (1984). (Pubitemid 15224431)
14. Grace, A. A. & Onn, S. P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J. Neurosci. 9, 3463-3481 (1989). (Pubitemid 19260019)
15. Pothos,E. N., Davila, V. & Sulzer, D. Presynaptic recordingofquanta from midbrain dopamine neurons and modulation of the quantal size. J. Neurosci. 18, 4106-4118 (1998). (Pubitemid 28243807)
16. Staal, R. G. W., Mosharov, E. V. & Sulzer, D. Dopamine neurons release transmitter via a flickering fusion pore. Nature Neurosci. 7, 341-346 (2004). (Pubitemid 38429173)
17. Simeone, A. Genetic control of dopaminergic neuron differentiation. Trends Neurosci. 28, 62-65 (2005).
18. Zappone, M. V. et al. Sox2 regulatory sequences direct expression of a b-geo transgenetotelencephalic neural stemcellsandprecursorsofthemouse embryo, revealing regionalization of gene expressionin CNS stem cells. Development 127, 2367-2382 (2000). (Pubitemid 30386576)
19. Pang, Z.P. et al. Induction ofhuman neuronal cellsbydefined transcription factors. Nature advance online publication, doi:10.1038/nature10202 (26 May 2011).
20. Pfisterer, U. et al. Direct conversionof human fibroblaststodopaminergic neurons. Proc. Natl Acad. Sci. USA doi:10.1073/pnas.1105135108 (6 June 2011).
21. Amariglio, N. et al. Donor-derived brain tumor following neural stem cell transplantationinanataxia telangiectasia patient. PLoS Med. 6, e1000029 (2009).
22. Sironi, F. et al. a-Synuclein multiplication analysis in Italian familial Parkinson disease. Parkinsonism Relat. Disord. 16, 228-231 (2010).
23. Sironi, F. et al. Parkin analysis in early onset Parkinson's disease. Parkinsonism Relat. Disord. 14, 326-333 (2008). (Pubitemid 351736002)
24. Pruszak, J.et al. Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons from rodent brain. Curr. Prot. Stem Cell Biol. Chapter 2, 2D.5.1-2D.5.21 (2009).
25. Broccoli, V. et al. The caudal limit of Otx2 expression positions the isthmic organizer. Nature 401, 164-168 (1999). (Pubitemid 29436319)
26. Irizarry, R. A. et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003)
27. Smyth, G.K. Linearmodels and empirical Bayesmethods forassessingdifferential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article 3 (2004).
28. Hochberg, Y. & Benjamini, Y. More powerful procedures for multiple significance testing. Stat. Med. 9, 811-818 (1990). (Pubitemid 20343989)
29. Huang, D. W. et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
30. Biagioli, M. et al. Unexpected expression of a-and b-globin in mesencephalic dopaminergic neurons and glial cells. Proc. Natl Acad. USA 106, 15454-15459 (2009).
31. Pothos, E., Desmond, D. & Sulzer, D. L-3,4-Dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro. J. Neurochem. 66, 629-636 (1996).
32. Mundroff, M. L. & Wightman, R. M. Amperometry and cyclic voltammetry with carbon fiber microelectrodes at single cells. Curr. Protoc. Neurosci. Chapter 6, 6.14.1-6.14.22 (2002).
33. 21-dependent synaptic activity. J. Neurosci. 26, 11670-11681 (2006). (Pubitemid 44772139)
34. Colasante, G. et al. Arx is a direct target of Dlx2 and thereby contributes to the tangential migration of GABAergic interneurons. J. Neurosci. 28, 10674-10686 (2008).
35. West, M. J. et al. Unbiased stereological estimation of the total number of neurons in thesubdivisionsofthe rat hippocampus using the optical fractionator. Anat. Rec. 231, 482-497 (1991).
36. Bacigaluppi, M. et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 132, 2239-2251 (2009).